tiprankstipranks
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
US Market

Tarsus Pharmaceuticals (TARS) Balance Sheet

149 Followers

Tarsus Pharmaceuticals Balance Sheet

Tarsus Pharmaceuticals's total assets for Q4 2023 were $265.49M, a decrease of -1.06% from the previous quarter. TARS total liabilities were $68.50M for the fiscal quarter, a 25.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 265.49M$ 227.86M$ 178.91M$ 171.97M$ 58.32M
Total Liabilities
$ 68.50M$ 34.96M$ 12.18M$ 5.99M$ 64.32M
Total Equity Gross Minority
$ 196.99M$ 192.90M$ 166.70M$ 165.98M$ -6.00M
Total Capitalization
$ 256.63M$ 212.33M$ 166.73M$ 165.98M$ -6.00M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 831.00K$ 164.00K
Currency in USD

Tarsus Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis